Extracted from: Dr J. Jarricot, "Le dispensaire marin", Paris, Masson 1924
QUINTON Marine Plasma -
A Pre-natal Subcutaneous Treatment
We have been fortunate to practice the subcutaneous Marine Treatment on women, seeking optimum foetal development, and have determined by routine observations in our Dispensaries that the Quinton Marine Plasma treatment is the most effective on hereditary taints when the foetus is very young. In this way, many afflictions (micro-encephalus, hydrocephalus, carnial swellings and abnormalities, symptoms of rickets etc.,) respond fastest to the use of QMP when practiced early on in the tainted subject. We thought it probable that QMP injections would act favorably on the foetus and therefore instituted the Marine Treatment, on an experimental basis, on a certain number of women whose previous pregnancies were either stillborn, or who gave birth to abnormal subjects.
We know that tubercular heredity and, even more so, syphilitic heredity, causes a great number of premature births, many still-births, and an elevated death rate during the first few days of life. Henri Leduc (Thesis, Paris 1905-1906) has found a death rate of 71% for syphilitic heredity in his maternity ward statistics of the Tenon hospital and this data was collected only from subjects that succumbed during pregnancy or during the first eleven days of their existence. Viable children, born by tainted mothers, are often mentally deficient, have reduced weight, and this is proof that they were hindered during their intra-uterine life. All, or nearly all, exhibit anatomical anbormalities relating back to their pathognomonical origin. Their eventual evolution is generally retarded. Athrepsia and atrophy develops in a notable proportion of these children. Many die during the first year of one of the known afflictions that usually strike them.
So, as much as we can conclude from still too few, but typical, observations, the subcutaneous QMP treatment, practiced on a woman who is pregnant, tubercular or syphilitic, seems:
to bring to term the majority of conceived beings;
to prevent still-births;
to permit a just about normal development of the fetus and thus raise the possibility of an elevated weight at birth;
to curb the mortality rate of the first days, the first month and even the first years;
to counteract athrepsia and atrophy;
and finally, to act so powerfully on the original taint, that the atomic abnormalities that are so characteristic of hereditarily challenged children tend to become erased with children that have been subjected to prenatal Marine Treatment.
This is how we see in four observations, the only ones we have on mothers that had at least five previous pregnancies before the treatment, that the latter decreases the percentage of premature births from 28% to 0%, the rate of still-births from 14% to 0%, the death rate of infants before they attain the age of 1 year from 59% to 0%.
QMP injections, performed on a pregnant woman, seems to act preferentially on the development of the foetus and its ulterior destiny. Still, in most of our observations, the subcutaneous Marine Treatment was instituted only very late and irregularly. Should we expect superior results from a methodical treatment that runs from the beginning to the end of the pregnancy and prolonged on the child during the first months of its life?
The subjects treated by us during their intrauterine life are still young and we cannot guarantee their ultimate evolution. Nevertheless, the results that were obtained seem to be most encouraging, given the fact that the most serious case that we had to treat (with a history of three still-births, two deaf-mutes, two premature deaths in previous pregnancies), the two subjects submitted by us to the prenatal Marine Treatment, are now eleven and eight years old. The only one we were able to see again presented at seven years of age, had all the characteristics of a normal child, without any anatomical abnormalities, other than a facial reduction.
It definitely seems that with the subcutaneous Marine Treatment we have, right now, a weapon with which to combat syphilitic heredity and to obtain more or less viable and close to normal offspring from tainted parents.
|
